No Data
Hong Kong stock market afternoon review | The hang seng index rose 0.42% in the morning session, with most pharmaceutical stocks advancing.
The results of the medical insurance negotiation are about to be announced. Institutions point out that the sector still has further room for repair.
Hong Kong stocks concept tracking | The commercialization trend of surgical siasun robot&automation is obvious, and the prospect of domestic substitution is broad (with concept stocks)
Over 30,000 kilometers, the siasun robot&automation's remote surgery in china once again achieved a breakthrough.
China Post Securities: The old-for-new policy has entered the implementation phase, and the medical devices sector is expected to enter a period of high performance growth.
It is expected that in December and the first quarter of 2025, various provinces will gradually implement the trade-in policy, relevant hospital tenders will be initiated, and equipment manufacturers are expected to see a large number of trade-in orders in the fourth quarter.
Hong Kong stock movement | MicroPort Robotics-B (02252) is currently up nearly 5%. Timai Robotics has made further breakthroughs in remote surgery, with a cumulative total of 10 siasun robots&automation orders on hand overseas.
Minimally Invasive siasun robot&automation-B (02252) is now up nearly 5%, as of the deadline for submission, up 4.74%, trading at 9.52 Hong Kong dollars, with a turnover of 36.822 million Hong Kong dollars.
Hong Kong stock midday review | Hang Seng Index fell 1.73% in the morning, while medical instruments stocks rose.
Medical insurance prepayment is expected to accelerate enterprise receivables, and innovative medical devices will usher in a new growth space.
Hong Kong stocks fluctuate | Medical device stocks rise, medical insurance prepayment is expected to accelerate the company's receivables, innovative devices will usher in new volume space.
Most medical equipment stocks have risen. As of the time of publication, Microport (00853) rose by 5.01% to HK$6.92; Sh Pharma (02607) rose by 4.05% to HK$13.36; Sinopharm (01099) rose by 3.14% to HK$21.35.
No Data
No Data
